Global Presence. Export More than 70 Country. Year to Year Revenue Growth Positive. FY 2020-21 630+ Cr., FY 2021-22 736+ Cr. & FY 2022-23 888+ Cr & Profit Growth is Positive FY 2020-21 235 Cr, FY 2022-23 240+ Cr. & Main Positive side of Concord Biotech, Company Borrowing is Reduce year to year. Total Borrowing FY 2020-21 Rs. 86.35 Cr., FY 2021-22 Rs. 60.59 Cr. & FY 2022-23 Rs. 31.24 Cr. Very Positive.